Global Preventive Healthcare Technology 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR072509561

Publication Date:

July 15, 2025

Pages:

108

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Preventive Healthcare Technology market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Preventive Healthcare Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Preventive Healthcare Technology market size and forecasts, in consumption value ($ Million), 2020-2031
Global Preventive Healthcare Technology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Preventive Healthcare Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Preventive Healthcare Technology market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Preventive Healthcare Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Preventive Healthcare Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 23andMe, MyHeritage, Myriad Genetics, Quest Diagnostics, Medtronic, Abbott, Merck, GlaxoSmithKline, Sanofi, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Preventive Healthcare Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Gene Testing & Screening
Vaccines
麻豆原创 segment by Application
Adults
Children
麻豆原创 segment by players, this report covers
23andMe
MyHeritage
Myriad Genetics
Quest Diagnostics
Medtronic
Abbott
Merck
GlaxoSmithKline
Sanofi
Pfizer
China National Biotec
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Preventive Healthcare Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Preventive Healthcare Technology, with revenue, gross margin, and global market share of Preventive Healthcare Technology from 2020 to 2025.
Chapter 3, the Preventive Healthcare Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Preventive Healthcare Technology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Preventive Healthcare Technology.
Chapter 13, to describe Preventive Healthcare Technology research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Preventive Healthcare Technology by Type
1.3.1 Overview: Global Preventive Healthcare Technology 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Preventive Healthcare Technology Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Gene Testing & Screening
1.3.4 Vaccines
1.4 Global Preventive Healthcare Technology 麻豆原创 by Application
1.4.1 Overview: Global Preventive Healthcare Technology 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Adults
1.4.3 Children
1.5 Global Preventive Healthcare Technology 麻豆原创 Size & Forecast
1.6 Global Preventive Healthcare Technology 麻豆原创 Size and Forecast by Region
1.6.1 Global Preventive Healthcare Technology 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Preventive Healthcare Technology 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Preventive Healthcare Technology 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Preventive Healthcare Technology 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Preventive Healthcare Technology 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Preventive Healthcare Technology 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Preventive Healthcare Technology 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 23andMe
2.1.1 23andMe Details
2.1.2 23andMe Major Business
2.1.3 23andMe Preventive Healthcare Technology Product and Solutions
2.1.4 23andMe Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 23andMe Recent Developments and Future Plans
2.2 MyHeritage
2.2.1 MyHeritage Details
2.2.2 MyHeritage Major Business
2.2.3 MyHeritage Preventive Healthcare Technology Product and Solutions
2.2.4 MyHeritage Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 MyHeritage Recent Developments and Future Plans
2.3 Myriad Genetics
2.3.1 Myriad Genetics Details
2.3.2 Myriad Genetics Major Business
2.3.3 Myriad Genetics Preventive Healthcare Technology Product and Solutions
2.3.4 Myriad Genetics Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Myriad Genetics Recent Developments and Future Plans
2.4 Quest Diagnostics
2.4.1 Quest Diagnostics Details
2.4.2 Quest Diagnostics Major Business
2.4.3 Quest Diagnostics Preventive Healthcare Technology Product and Solutions
2.4.4 Quest Diagnostics Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Quest Diagnostics Recent Developments and Future Plans
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business
2.5.3 Medtronic Preventive Healthcare Technology Product and Solutions
2.5.4 Medtronic Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Medtronic Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Preventive Healthcare Technology Product and Solutions
2.6.4 Abbott Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Preventive Healthcare Technology Product and Solutions
2.7.4 Merck Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Merck Recent Developments and Future Plans
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Preventive Healthcare Technology Product and Solutions
2.8.4 GlaxoSmithKline Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 GlaxoSmithKline Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Preventive Healthcare Technology Product and Solutions
2.9.4 Sanofi Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Preventive Healthcare Technology Product and Solutions
2.10.4 Pfizer Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 China National Biotec
2.11.1 China National Biotec Details
2.11.2 China National Biotec Major Business
2.11.3 China National Biotec Preventive Healthcare Technology Product and Solutions
2.11.4 China National Biotec Preventive Healthcare Technology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 China National Biotec Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Preventive Healthcare Technology Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Preventive Healthcare Technology by Company Revenue
3.2.2 Top 3 Preventive Healthcare Technology Players 麻豆原创 Share in 2024
3.2.3 Top 6 Preventive Healthcare Technology Players 麻豆原创 Share in 2024
3.3 Preventive Healthcare Technology 麻豆原创: Overall Company Footprint Analysis
3.3.1 Preventive Healthcare Technology 麻豆原创: Region Footprint
3.3.2 Preventive Healthcare Technology 麻豆原创: Company Product Type Footprint
3.3.3 Preventive Healthcare Technology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Preventive Healthcare Technology Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Preventive Healthcare Technology 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Preventive Healthcare Technology Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Preventive Healthcare Technology 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Preventive Healthcare Technology Consumption Value by Type (2020-2031)
6.2 North America Preventive Healthcare Technology 麻豆原创 Size by Application (2020-2031)
6.3 North America Preventive Healthcare Technology 麻豆原创 Size by Country
6.3.1 North America Preventive Healthcare Technology Consumption Value by Country (2020-2031)
6.3.2 United States Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Preventive Healthcare Technology Consumption Value by Type (2020-2031)
7.2 Europe Preventive Healthcare Technology Consumption Value by Application (2020-2031)
7.3 Europe Preventive Healthcare Technology 麻豆原创 Size by Country
7.3.1 Europe Preventive Healthcare Technology Consumption Value by Country (2020-2031)
7.3.2 Germany Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Preventive Healthcare Technology Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Preventive Healthcare Technology Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Preventive Healthcare Technology 麻豆原创 Size by Region
8.3.1 Asia-Pacific Preventive Healthcare Technology Consumption Value by Region (2020-2031)
8.3.2 China Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Preventive Healthcare Technology Consumption Value by Type (2020-2031)
9.2 South America Preventive Healthcare Technology Consumption Value by Application (2020-2031)
9.3 South America Preventive Healthcare Technology 麻豆原创 Size by Country
9.3.1 South America Preventive Healthcare Technology Consumption Value by Country (2020-2031)
9.3.2 Brazil Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Preventive Healthcare Technology Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Preventive Healthcare Technology Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Preventive Healthcare Technology 麻豆原创 Size by Country
10.3.1 Middle East & Africa Preventive Healthcare Technology Consumption Value by Country (2020-2031)
10.3.2 Turkey Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Preventive Healthcare Technology 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Preventive Healthcare Technology 麻豆原创 Drivers
11.2 Preventive Healthcare Technology 麻豆原创 Restraints
11.3 Preventive Healthcare Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Preventive Healthcare Technology Industry Chain
12.2 Preventive Healthcare Technology Upstream Analysis
12.3 Preventive Healthcare Technology Midstream Analysis
12.4 Preventive Healthcare Technology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

23andMe
MyHeritage
Myriad Genetics
Quest Diagnostics
Medtronic
Abbott
Merck
GlaxoSmithKline
Sanofi
Pfizer
China National Biotec

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.